Prognostic evaluation of patients with parenchymal cirrhosis. Proposal of a new simple score

Journal of Hepatology

Volumn 26, Issue 3, 1997, Pages 642-649

  Adler, Michael ^a   Verset, Didier ^a   Bouhdid, Hassan ^a   Bourgeois, Nadine ^a   Gulbis, Béatrice ^a   Le Moine, Olivier ^a   Van De Stadt, Jean ^a   Gelin, Michel ^a   Thiry, Philippe ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

liver cirrhosis; liver transplantation; prognosis

Indexed keywords

ARTICLE; BREATH ANALYSIS; HUMAN; LABORATORY TEST; LIVER CIRRHOSIS; LIVER PARENCHYMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031041357     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80431-X     Document Type: Article

References (32)

1. McIntyre N, Rosalki S. Biochemical investigation in the management of liver disease. Pietro J, Rodes J, Shafritz DA. Hepatobiliary Disease. 1992;39-41 Springer Verlag, Berlin.
2. Adler M, Bourgeois N, Van de Stadt J, Gelin M. A Pugh score of 8 adequately selects patients with parenchymal cirrhosis for liver transplantation. Transplant Int. 5:1992;175-178.
3. Merkel C, Bolognesi M, Bellow S, Bianco S, Honisen B, Lampe H, Angeli P, et al. Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut. 33:1992;836-842.
4. Blake J, Orrego H. Monitoring treatment of alcoholic liver disease: evaluation of various severity indices. Clin Chem. 37:1991;5-13.
5. Oellerich M, Burdelski M, Lautz HU, Binder L, Pichlmayr R. Predictors of one-year pretransplant survival in patients with cirrhosis. Hepatology. 14:1991;1029-1034.
6. Anthony PP, Ishaf KG, Nayaf NC, Poulsen HE, Scheuer PJ, Sobin LH. The morphology of cirrhosis: recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol. 31:1978;395-414.
7. Adler M, Van Laethem J, Glibert A, Gelin M, Bourgeois N, Vereerstraeten P, Cremer M. Factors influencing survival at one year in patients with non biliary hepatic parenchymal cirrhosis. Dig Dis Sci. 35:1990;1-5.
8. Adams RD, Foley JA. Neurological changes in more common type of severe liver disease. Trans Am Neurol Assoc. 74:1949;217-219.
9. Zoppi L, Fumagali C. Improved measurement of MEGX in serum with the Abbott TDX. Clin Chem. 38:1992;441-442.
10. Gehan E. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika. 52:1965;203-223.
11. Erdreich LS, Lee ET. Use of relative operating characteristic analysis in epidemiology. Am J Epidemiol. 114:1981;649-662.
12. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 60:1973;646-649.
13. Orrego H, Israel Y, Blake JE, Medline A. Assessment of prognostic factors in alcoholic liver disease: toward a global quantitative expression of severity. Hepatology. 3:1983;896-905.
14. Pignon JP, Poynard T, Naveau S, Marteau P, Zourabien-Vilio, Chaput JC. Analyse multidimensionnelle selon le modèle de Cox de la survie de patients atteints de cirrhose alcoolique. Gastroenterol Clin Biol. 10:1986;461-467.
15. Draper N, Smith H. 2nd edn. Applied Regression Analysis. 1981;84-88 John Wiley and Sons, New York.
16. Youden WJ. Index for rating diagnostic tests. Cancer. 3:1950;32-35.
17. Hirsch RP, Riegelman RK. Statistical First Aid, Interpretation of Health Research Data. 1992;193-194 Blackwell Scientific Publications, Oxford.
18. Tygstrup N. Assessment of liver function: principles and practice. J Gastroenterol Hepatol. 5:1990;468-482.
19. Evans DB, Lehmann M. Pseudo cholinesterase activity in liver transplantation. Lancet. i:1971;1040-1044.
20. Schlichting D, Christensen E, Andersen PK, et al. Prognostic factors in cirrhosis identified by Cox's regression model. Hepatology. 3:1983;889-895.
21. Saheki S, Ochi M, Horiuchi T, Sakagishi Y, Fujimori-Arai Y, Koyama I, Komoda T, Takeuchi N. Intestinal type alkaline phosphatase hyperphosphatasemia associated with liver cirrhosis. Clin Chim Acta. 210:1992;63-73.
22. Mannes GA, Thieme C, Stellaard F, Wang T, Sauerbruch T, Paumgartner G. Prognostic significance of serum bile acids in cirrhosis. Hepatology. 6:1986;50-53.
23. Schneider JF, Baker AL, Haines NW, et al. Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease. Gastroenterology. 79:1980;1145-1150.
24. Villeneuve JP, Infante-Rivard C, Amdelas M, Pomier-Layragues G, Huet PM, Marleau D. Prognostic value of the amino-pyrine breath test in cirrhotic patients. Hepatology. 6:1986;928-931.
25. Gremse DA, A-Kader HH, Schroeder TJ, Bastreir WF. Assessment of lidocaine metabolite formation as a quantitative liver function in children. Hepatology. 12:1990;565-569.
26. Arrigoni A, Gindro T, Aimo G, Cappello N, Meloni A, et al. Monoethylglycinexylidide test: a prognostic indicator of survival in cirrhosis. Hepatology. 20:1994;383-387.
27. Benowitz NL, Meister W. Clinical pharmacokinetics of lignocaine. Clin Pharmacokin. 177:1978;201.
28. Saunders JB. Early diagnosis of alcoholic cirrhosis by the aminopyrine breath test. Gastroenterology. 79:1980;112-114.
29. 14C ethanol breath test in alcoholic liver disease. Clin Chim Acta. 86:1978;121-123.
30. Lautz HU, Pichlmayr R. Special aspects of timing of liver transplantation in patients with liver cirrhosis. Baillière's Clin Gastroenterol. 3:1989;743-756.
31. Bouchier IAD, Hislop WS, Prescott RJ. A prospective study of alcoholic liver disease and mortality. J Hepatol. 19:1992;290-297.
32. Hashizume M, Inokuchi K, Beppu K, et al. The natural history of non-alcoholic cirrhosis. Gastroenterol Japonica. 19:1984;430-435.